Top Biotechnology & Medical Research stocks in Switzerland
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LONNLonza AG | CH₣37.47bn | 36.08 | 0.77% |
BANBBACHEM HOLDING AG | CH₣6.02bn | 53.43 | 1% |
BIONBB Biotech AG | CH₣2.31bn | 7.52 | 4.74% |
BSLNBasilea Pharmaceutica AG Allschwil | CH₣478.07m | 45.78 | n/a |
IDIAIdorsia | CH₣360.78m | n/a | n/a |
KURNKuros Biosciences AG | CH₣245.78m | n/a | n/a |
XLSXlife Sciences AG | CH₣191.06m | 16.07 | n/a |
MOLNMolecular Partners AG | CH₣111.75m | n/a | n/a |
RLFRELIEF THERAPEUTICS Holding SA | CH₣14.23m | n/a | n/a |
ADXNAddex Therapeutics | CH₣8.37m | n/a | n/a |
EVEEvolva Holding | CH₣6.52m | n/a | n/a |
OBSNObseva SA | CH₣0.14m | 0.04 | n/a |